Form
SCHEDULE 13G/A
Passive or exempt beneficial ownership filing.
Kynam Capital Management, LP - 11 Mar 2025 SCHEDULE 13G/A Report for 2seventy Bio, Inc. Common Stock, par value $0.0001 per share (TSVT)
- Filing manager
- Kynam Capital Management, LP
- Reporting owner
- Kynam Capital Management, LP
- Beneficially owned shares
- 0 shares
- Large-stake signal
-
Ownership
0%Beneficial ownership of this reported class.
Shares
0 sharesShares beneficially owned as disclosed.
Event date
11 Mar 2025Date tied to the ownership event or amendment.
Accepted by SEC
17 Mar 2025EDGAR acceptance date.
How to read this large-stake filing
- Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
- Compare this filing with the holder history and issuer page before treating the percentage as a current position.
- Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
- Class ownership
- 0%
- Symbol
- TSVT
- SEC form
- SCHEDULE 13G/A
- Accepted by SEC
- 17 Mar 2025, 10:54:33 UTC
- Event date
- 11 Mar 2025
- Source filing
- View source filing
Ownership signal
CIK-linked ownership evidence from parsed SEC filings.
2 signals
Subject security
Names, identifiers, and filing context for this profile.
1 source field
Source evidence
Original filing metadata and source links for verification.
4 source fields
Key filing fact
Kynam Capital Management, LP disclosed 0% ownership in 2seventy Bio, Inc. Common Stock, par value $0.0001 per share (TSVT) on 11 Mar 2025.
Key facts
- Kynam Capital Management, LP filed SCHEDULE 13G/A for 2seventy Bio, Inc. Common Stock, par value $0.0001 per share (TSVT).
- Disclosed ownership: 0%.
- Date of event: 11 Mar 2025.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 17 Mar 2025, 10:54.
Research use
- This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
- Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.
Evidence
Backed by Schedule 13D/13G
View source filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Disclosed reporting parties (5)
Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares owned | Sole voting power | Shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Kynam Capital Management, LP | 0% | 0 | 0 | 0 | Yue Tang | Managing Member of its General Partner | |
| Kynam Capital Management GP, LLC | 0% | 0 | 0 | 0 | Yue Tang | Managing Member | |
| Yue Tang | 0% | 0 | 0 | 0 | Yue Tang | Self | |
| Kynam Global Healthcare Master Fund, LP | 0% | 0 | 0 | 0 | Yue Tang | Managing Member of its General Partner | |
| Kynam Fund GP, LLC | 0% | 0 | 0 | 0 | Yue Tang | Managing Member |
CIK / CUSIP context first